M

Massive Bio

56 employees

Massive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients.

Basic info

Industry

hospital & health care

Sectors

Biotechnology
precision oncology
Artificial Intelligence
Natural Language Processing
Big Data
Cancer Treatment
Oncology
Pharmaceutical
Clinical Trials
Machine Learning
Clinical trial selection
Cancer genomics
Targeted cancer therapies
Health Care
Tumor profiling technologies
Therapeutics
personalized cancer treatment options
Cancer Research
Medical
Second Opinion
Cancer Care

Date founded

2014

Funding rounds raised

Total raised

$17M

from 7 investors over 7 rounds

M

Massive Bio raised $17M on June 2, 2022

Investors: Revo Capital, SiteGround Web Hosting Company, IFC Asset Management Company (AMC) and ImpactAssets

M

Massive Bio raised $2.8M on November 3, 2020

Investors: Revo Capital

M

Massive Bio raised $2M on May 2, 2019

Investors: International Private Bank

M

Massive Bio raised undisclosed on April 3, 2015

Investors: 500 Startups

FAQ